日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes

Lecanemab 用于治疗早期阿尔茨海默病 (AD) 患者,这些患者为载脂蛋白 E ε4 (ApoE ε4) 非携带者或杂合子。

Perry, Richard; Kipps, Christopher; Soto Martín, Maria Eugenia; Bozzali, Marco; Logroscino, Giancarlo; Trafford, Sarah; Dhadda, Shobha; Kanekiyo, Michio; Goodwin, Amanda; Hodgkinson, Mark; Hersch, Steven; Irizarry, Michael; Kramer, Lynn; Froelich, Lutz

Corrigendum to "Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes" [The Journal of Prevention of Alzheimer's Disease (2026) 100507]

对“Lecanemab 用于治疗载脂蛋白 E ε4 (ApoE ε4) 非携带者或杂合子早期阿尔茨海默病 (AD) 患者的更正”[阿尔茨海默病预防杂志 (2026) 100507]

Perry, Richard; Kipps, Christopher; Martín, Maria Eugenia Soto; Bozzali, Marco; Logroscino, Giancarlo; Trafford, Sarah; Dhadda, Shobha; Kanekiyo, Michio; Goodwin, Amanda; Hodgkinson, Mark; Hersch, Steven; Irizarry, Michael; Kramer, Lynn; Froelich, Lutz

A glycoengineered anti-ROR1 antibody, GE-zilovertamab, selectively enhances antibody-dependent cellular cytotoxicity against chronic lymphocytic leukemia

一种糖基化改造的抗ROR1抗体GE-zilovertamab可选择性地增强抗体依赖性细胞毒性,从而对抗慢性淋巴细胞白血病。

Hasan, Md Kamrul; Widhopf Ii, George; Kipps, Thomas J

Co-Design of a New Integrated Care Model With People Affected by Huntington's Disease: A Mixed Methods Study

与亨廷顿病患者共同设计新型整合照护模式:一项混合方法研究

Pires, Sandra Bartolomeu; Kunkel, Dorit; Manera, Karine; Goodwin, Nicholas; Kipps, Christopher; Portillo, Mari Carmen

Bridging the gap: the role of student conferences in advancing sport and exercise medicine in the medical school curricula

弥合差距:学生会议在推进医学院课程中的运动与锻炼医学方面的作用

Ali, Yunus; Monaghan, George; Wisking, Allegra; Ojo, Demi; Zieler, Iris; Ghanekar, Eeshaan; Kipps, Courtney

Alzheimer's disease diagnosis support for brain perfusion SPECT scans in a real-world clinical cohort

真实世界临床队列中脑灌注SPECT扫描对阿尔茨海默病诊断的支持作用

Michopoulou, Sofia; Prosser, Angus; O'Brien, Neil; Dickson, John; Guy, Matthew; Teeling, Jessica L; Kipps, Christopher M

REMOTE-Neuro: co-produced recommendations to optimise remote neurology

远程神经病学:共同制定优化远程神经病学的建议

Fuller, Patricia; Fearn, Sarah; Dace, Sally; Wollam, Amanda; Zarkali, Angeliki; Cowan, Adam; Mountney, Sam; Carr, Georgina; Eriksson, Sofia H; Kipps, Christopher

Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL

RESONATE-2 研究的最终分析:对慢性淋巴细胞白血病/小淋巴细胞淋巴瘤一线伊布替尼治疗进行长达 10 年的随访。

Burger, Jan A; Barr, Paul M; Robak, Tadeusz; Owen, Carolyn; Tedeschi, Alessandra; Sarma, Anita; Patten, Piers E M; Grosicki, Sebastian; McCarthy, Helen; Offner, Fritz; Szafer-Glusman, Edith; Zhou, Cathy; Szoke, Anita; Neumayr, Lynne; Dean, James P; Ghia, Paolo; Kipps, Thomas J

The MURANO study: final analysis and retreatment/crossover substudy results of VenR for patients with relapsed/refractory CLL

MURANO 研究:VenR 治疗复发/难治性 CLL 患者的最终分析和再治疗/交叉亚组研究结果

Kater, Arnon P; Harrup, Rosemary; Kipps, Thomas J; Eichhorst, Barbara; Owen, Carolyn J; Assouline, Sarit; Lamanna, Nicole; Robak, Tadeusz; de la Serna, Javier; Jaeger, Ulrich; Cartron, Guillaume; Montillo, Marco; Mellink, Clemens; Langerak, Anton W; Chyla, Brenda; Popovic, Relja; Jiang, Yanwen; Millen, Rosemary; Lefebure, Marcus; Thadani-Mulero, Maria; Boyer, Michelle; Seymour, John F

Retreatment with venetoclax and rituximab following disease progression while off therapy in patients with chronic lymphocytic leukemia

慢性淋巴细胞白血病患者停药后疾病进展,可使用维奈托克和利妥昔单抗进行再治疗

Brander, Danielle M; Roberts, Andrew W; Kipps, Thomas J; Ma, Shuo; Anderson, Mary Ann; Boyer, Michelle; Blombery, Piers; Popovic, Relja; Roser, Jordan; Liu, Zhuangzhuang; Chyla, Brenda; Seymour, John F